Keywords: ionix, ix-1003, completes, phase, studies, trials, been

Ionix' IX-1003 completes Phase I studies

Article | 21 July 2003

Phase I trials have been successfully completed for Ionix Pharmaceuticals' IX-1003. The product is a proprietary intranasal formulation of the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Buprenex

Buprenorphine

Go to drug listing